PhRMA Lauds Obama's Emphasis on Importance of Innovation

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p57
Trade Publication
The article reports that executives at the Pharmaceutical Research and Manufacturers of America (PhRMA) has applauded the call of U.S. President Barack Obama for leadership in product development and manufacturing in his speech to the Chamber of Commerce in Washington.


Related Articles

  • PhRMA throws ad weight behind reform as debates get heated.  // Drug Store News;9/14/2009, Vol. 31 Issue 10, p100 

    The article focuses on the advertising campaign by the Pharmaceutical Research and Manufacturers of America (PhRMA) in support of healthcare reform planned by U.S. President Barack Obama. The campaign include television, radio and print advertisements in 12 important states. It focused on...

  • Innovation's Role Receives Recognition.  // Chain Drug Review;7/20/2009, Vol. 31 Issue 12, p106 

    The article reports on the recognition and commendation made by Billy Tauzin, chief executive officer (CEO) of Pharmaceutical Research and Manufacturers of America for President Barack Obama for highlighting the importance of innovation in improving the country's economy. It mentions that the...

  • Barack Obama. Arnold, Matthew // Medical Marketing & Media;May2008, Vol. 43 Issue 5, p14 

    The article presents comments of the U.S. presidential candidate Barak Obama on Billy Tauzin, the chief executive of Pharmaceutical Research and Manufacturers of America (PhRMA) during an advertising after him. Obama stated that the chairman of a pharmaceutical industry who wrote into the...

  • Eliminating the Donut Hole and Other Proposed Medicare Part D Reforms. Goel, Ankur J.; Hance, Anne W.; Michaels, Joel L. // Venulex Legal Summaries;2009 Q3, Special section p1 

    The article reports on a bill to improve access to brand-name prescription drugs for Medicare beneficiaries within the coverage gap of their Part D Plan announced by U.S. President Barack Obama, Senator Max Baucus and the Pharmaceutical Research and Manufacturers of America (PhRMA) on June 20,...

  • The 80 Billion Dollar Question. Paul, Reid // Pharmaceutical Representative;Sep2009, Vol. 39 Issue 9, p6 

    The article reports on the issue concerning the deal agreed by the Pharmaceutical Research and Manufacturers of America (PhRMA) with the U.S. Congress to receive $80 billion of funds as part of health care reform. Pharmaceutical companies raised their concern that the amount will not be enough...

  • Tracking Washington.  // MondayMorning;12/5/2011, Vol. 19 Issue 44, p6 

    The article reports on the brokered deal made by American lobbyist and politician Billy Tauzin, to U.S. President Barack Obama. The deal has helped Obama to pass the healthcare reform where he left his position as chief executive officer (CEO) of PhRMA, a pharmaceutical company lobby group....

  • White House Budget Includes FDA Increases for FY 2013.  // BioPharm International;Mar2012, Vol. 25 Issue 3, p12 

    The article reports on the 4.49 billion dollar budget proposal of U.S. President Barack Obama for the U.S. Food and Drug Administration (FDA) for the fiscal year 2013. It states that the budget will provide for the efficient performance of FDA's responsibilities public health, product...

  • President Obama unveils plans for manufacturing centres.  // Engineer (Online Edition);5/10/2013, p4 

    The article discusses the plans of U.S. President Barack Obama to build a series of manufacturing centres to bridge the gap between basic research and product development. In lieu of this, the government is launching competitions to create three manufacturing innovation institutes with a federal...

  • Groups Send Obama Detailed Proposal on Healthcare Cost Reduction.  // Aging News Alert;6/5/2009, p4 

    The article reports that health-related organizations who have pledged to support U.S. President Barack Obama's call for major reductions in the cost of healthcare have signed a joint letter spelling out their future plans. The groups include AdvaMed, the Pharmaceutical Research & Manufacturers...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics